Targeting the metabolic reprogramming associated with cdk4/6 inhibition as an effective combined therapy in colon cancer

  • No Comments

Targeting the metabolic reprogramming associated with cdk4/6 inhibition as an effective combined therapy in colon cancer

Targeting the metabolic reprogramming associated with cdk4/6 inhibition as an effective combined therapy in colon cancer 1241 1755 Metabolism & Cancer
Leave a Reply
Characterization by Mass Spectrometry of the lipid metabolism in the different molecular breast cancer subtypes
Metabolic profile of tumor skin cells after low-levellaser therapy
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here